World of Bacteria header image

Legionella pneumophila

Legionella pneumophila is a fastidious, strictly aerobic Gram-negative rod associated with natural and engineered water systems and is the principal cause of Legionnaires’ disease, a potentially severe form of pneumonia.

Basic Characteristics

Taxonomy

  • Domain: Bacteria
  • Phylum: Pseudomonadota (Proteobacteria)
  • Class: Gammaproteobacteria
  • Order: Legionellales
  • Family: Legionellaceae
  • Genus: Legionella
  • Species: Legionella pneumophila

Microscopy & Gram Stain

  • Slender, pleomorphic Gram-negative rods that may stain weakly by the Gram method
  • Cells usually occur singly; elongated and filamentous forms may appear in older cultures
  • Many strains are motile by means of polar or subpolar flagella

Oxygen Relationship

  • Strictly aerobic
  • Facultative intracellular organism that multiplies in free-living amoebae and human macrophages

Rapid Identification Tests

  • Growth requirement: L-cysteine and iron-enriched media
  • Growth on routine blood agar: absent
  • Catalase: positive
  • Oxidase: usually positive or weakly positive
  • Hippurate hydrolysis: positive
  • Urease: negative

Ecology and Clinical Relevance

Natural Habitat

  • Freshwater environments and aquatic biofilms
  • Hot-water systems, showers, cooling towers, spas, and other engineered water systems
  • Intracellular multiplication within free-living amoebae
  • Persistence in complex water-system biofilms

Common Clinical Specimens

  • Sputum and other lower respiratory tract specimens
  • Bronchoalveolar lavage and tracheal aspirates
  • Lung tissue
  • Urine for Legionella antigen testing
  • Environmental water samples during surveillance and outbreak investigations

Clinical Significance

  • Principal cause of Legionnaires’ disease, a potentially severe atypical pneumonia
  • May also cause Pontiac fever, a self-limited non-pneumonic illness
  • Risk is increased in older adults, smokers, people with chronic lung disease, and immunocompromised patients
  • Usually acquired by inhalation or aspiration of contaminated water aerosols rather than by person-to-person spread

Differential Considerations

  • Other Legionella species and non-pneumophila serogroups
  • Other fastidious Gram-negative rods that fail to grow on routine media
  • Other causes of severe community-acquired or healthcare-associated atypical pneumonia
  • A negative urinary antigen test does not exclude non-serogroup 1 L. pneumophila or other Legionella species

Diagnostic and Clinical Notes

Legionella pneumophila is an aquatic bacterium that persists in natural and engineered water systems, often within biofilms and free-living amoebae. Multiplication inside protozoa helps the organism survive environmental stress and prepares it for intracellular replication in human macrophages.

Culture requires buffered charcoal yeast extract agar or a related medium supplemented with L-cysteine and iron. GVPC medium adds selective agents that suppress competing environmental flora. Failure to inoculate appropriate media is a major reason why legionellae may remain undetected in routine cultures.

Colonies usually become visible after several days and may show a ground-glass, finely textured, opalescent, or iridescent appearance. These features are useful preliminary clues but remain presumptive and should be confirmed by antigenic, mass-spectrometric, or molecular methods.

For suspected Legionnaires’ disease, urinary antigen testing should be paired with testing of a lower respiratory specimen by culture or a molecular method. The commonly used urinary antigen test primarily detects L. pneumophila serogroup 1, so a negative result does not exclude infection caused by other serogroups or species.

Environmental recovery documents contamination of a water system but does not by itself prove the source of a human infection. Outbreak investigation may require comparison of clinical and environmental isolates by molecular typing or whole-genome sequencing.

Laboratory Identification

Colony Morphology

On BCYE or selective GVPC medium incubated at approximately 35–37 °C, Legionella pneumophila usually produces visible colonies after 2–5 days. Mature colonies may be small to medium-sized, convex or centrally raised, finely granular, ground-glass, opalescent, or iridescent. The organism does not grow on routine blood agar because it requires L-cysteine and iron.

Microscopy

Gram staining shows slender, pleomorphic Gram-negative rods that may stain faintly, particularly in direct clinical material. Preparations from mature colonies may contain elongated or filamentous forms. Microscopy supports recognition of the organism but is not sufficiently sensitive or specific for definitive diagnosis.

Key Identification Clues

  • Fastidious, strictly aerobic Gram-negative rod
  • Requires L-cysteine and iron-enriched BCYE-based media
  • No growth on routine blood agar or on BCYE lacking L-cysteine
  • Catalase positive and usually oxidase positive or weakly positive
  • Hippurate hydrolysis positive
  • Slow-growing ground-glass, opalescent, or iridescent colonies
  • Urinary antigen testing mainly detects L. pneumophila serogroup 1

Modern Identification Methods

Diagnosis may combine urinary antigen testing with culture or nucleic acid amplification from a lower respiratory specimen. Cultured isolates can be identified by MALDI-TOF mass spectrometry when the reference database is suitable, serological methods, or molecular assays. Whole-genome sequencing and other high-resolution typing methods are particularly useful for linking clinical and environmental isolates during outbreak investigations.

Antibiotic Characteristics

Legionella pneumophila replicates intracellularly, so effective therapy requires antimicrobial agents that penetrate host cells and remain active within the intracellular compartment.

Macrolides, particularly azithromycin, and respiratory fluoroquinolones such as levofloxacin are commonly used for Legionnaires’ disease. Prompt treatment is especially important in severe pneumonia and in high-risk patients.

Many beta-lactam agents are unsuitable because of limited intracellular activity and bacterial beta-lactamase production. In vitro susceptibility results do not always predict clinical efficacy for this intracellular organism.

Note: Routine susceptibility testing is not commonly performed for individual Legionella isolates. Treatment should follow current clinical guidance and take account of disease severity, host factors, contraindications, and local recommendations.

External Resources

For broader information about Legionella pneumophila, legionellosis, laboratory diagnosis, environmental sources, and current taxonomy, see: